Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flannelly Barry P
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Solomon Michael Edward
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SARGEN GREGORY
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Levy Richard S
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huang Jane
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GARCEAU ROGER
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BESHAR LUKE M
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
Protara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Protara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(5.7%),Citadel Advisors Holdings LP(5.7%), etc.
Protara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(5.3%),Heights Capital Management, Inc.(5.3%)
No Data